Rome consensus on gut microbiota and faecal microbiota transplantation in IBD
BMJ GroupEpisode Description
More Episodes
-
0Microbiome interventions for COPD protection
-
0MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
-
0RE.GA.IN: the Real-world Gastritis Initiative
-
0Prebiotic diet changes neural correlates of food decision-making in overweight adults
-
0Lethal sepsis prevention with novel tripeptide RKH derived from Akkermansia muciniphila
-
0Special Gut Podcast: Digestive health and climate change
-
0Gastrointestinal origins for Parkinson’s disease
-
0Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis
-
0The therapeutic potential of fasting
-
1Helicobacter pylori promotes colorectal carcinogenesis
-
0Single-cell transcriptomics sheds new light on pancreas biology and disease
-
0Counteracting the harm of dietary emulsifiers with Akkermansia muciniphila
-
0Antibiotic use as a risk factor for IBD
-
0Predicting disease progression in bridging fibrosis and cirrhosis with liver stiffness
-
0Assessing the impact of dietary fibre on bile acid transformation by gut bacteria in mice
-
0Autoimmune gastritis: cancer risk in consistently tested H. pylori-negative patients
-
0FMT-AID trial shows effectiveness in inducing remission of ulcerative colitis
-
0Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis
-
0Climate change: a survey of global gastroenterology society leadership
-
0Management of Helicobacter pylori infection — the Maastricht VI/Florence Consensus Report
-
0Kyoto international consensus report on the gastro-oesophageal junction
-
0A faecal microbiota signature with high specificity for pancreatic cancer
-
0PICaSSO Histologic Remission Index in ulcerative colitis: a novel simplified histological score
-
0Next-generation sequencing of bile cell-free DNA for early detection of malignant biliary strictures
-
0Endoscopic full-thickness plication for the treatment of PPI-dependent GERD
-
0Dysosmobacter welbionis, a new human commensal bacterium preventing diet-induced obesity
-
0Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Pg-LPS
-
0Proton pump inhibitors and risk of colorectal cancer
-
0Sugar-sweetened beverage intake and risk of early-onset colorectal cancer among women
-
0Diet quality and risk and severity of COVID-19: a prospective cohort study
-
0Helicobacter pylori resistance to antibiotics in Europe
-
0Blue poo: impact of gut transit time on the gut microbiome using a novel marker
-
0Long-term dietary patterns associated with inflammatory features of the gut microbiome
-
0Association between Brachyspira and irritable bowel syndrome with diarrhoea
-
0Effect of IBD medications on COVID-19 outcomes
-
0CLARITY IBD: Anti-SARS-CoV-2 antibody and vaccination responses in patients treated with infliximab
-
0Long-term instability of the intestinal microbiome and its associations
-
0Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis
-
0Screening and eradication of Helicobacter pylori for gastric cancer prevention
-
0European Registry on Helicobacter pylori management (Hp-EuReg)
-
0Driving the efficacy of prebiotic intervention in obese patients
-
0Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes
-
0Global burden of oesophageal and gastric cancer by histology and subsite in 2018
-
0Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
-
0Efficacy of FMT for patients with IBS in a randomised, double-blind, placebo-controlled study
-
0Infants born to mothers with IBD present with altered gut microbiome
-
0Mediterranean diet intervention alters the gut microbiome in older people
-
0Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus
-
0British Society of Gastroenterology guidance for management of IBD during the Covid-19 pandemic
-
0Global patterns and trends in colorectal cancer incidence in young adults
-
0Guidelines on the management of inflammatory bowel disease in adults
-
0European evidence-based guidelines on pancreatic cystic neoplasms
-
0Viral transfer during FMT linked to better outcomes in recurrent C. diff bacterial infections
-
0Colorectal cancer: research prioritisation needed in third most lethal malignancy worldwide
-
0Development of an FGF19-based chimeric molecule to promote fatty liver regeneration
-
0Feeding the microbiota: transducer of nutrient signals for the host
-
0Dietary emulsifiers directly alter human microbiota composition
-
0Faecal microbiota transplantation in clinical practice
-
0BMP-9 interferes with liver regeneration and promotes liver fibrosis
-
0A systematic review of isolated colonic Crohn’s disease: the third IBD?
-
0Gut microbiome and liver diseases
-
0Antibiotics as deep modulators of gut microbiota: between good and evil.
-
0Asia-Pacific consensus on the management of gastro-oesophageal reflux disease
-
0Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma
-
0Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn’s disease
-
0GLP-1 based therapies: clinical implications for gastroenterologists
-
0Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis
-
0Mesalazine and thymoquinone attenuate intestinal tumour development in mice
-
0Effects of bowel cleansing on the intestinal microbiota
-
0Development of an enhanced human gastrointestinal epithelial culture system
-
0Helicobacter pylori targets cancer-associated apical-junctional constituents
-
0Diagnosis and management of acute kidney injury in patients with cirrhosis
-
0Demonstration of the usefulness of epigenetic cancer risk prediction
-
0XIAP variants in male Crohn’s disease
-
0Cell lineage distribution atlas reveals heterogeneous gland populations in the gastric antrum
-
0Classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease
-
0Update on basic and clinical aspects of eosinophilic oesophagitis
-
0AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition
-
0Besifovir versus entecavir in Asian patients with chronic hepatitis B
-
0Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea
-
0Recent advances in clinical practice challenges and opportunities in the management of obesity
-
0Amniotic stem cell treament for necrotic enterocolitis
-
0British Society of Gastroenterology guidelines on diagnosing and managing Barrett’s oesophagus
-
0Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients
-
0A systematic approach to therapeutic target selection in oesophago-gastric cancer
-
0Gut podcast: Treatment of pancreatic fibrosis with siRNA
-
0Intra-tumoural stroma as a predictor of survival in patients with gastric cancer
-
0Probiotics in health and disease
-
0Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission
-
0mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway
-
0Endoscopic improvement of mucosal lesions in patients with ileocolonic Crohn’s disease
-
0Bowel cancer screening in England
-
0PUFAS and neoplasms
-
0Cancer treatment induced gastrointestinal symptoms
-
0Bifidobacterium and gastrointestinal inflammation
-
0High-fat diet and gut microbiota
-
1Management of Helicobacter pylori infection
-
0Assessment of colorectal cancer molecular features
-
0Probiotic and postbiotic activity in health and disease
-
0NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
-
0Outcomes of the Bowel Cancer Screening Programme in England
-
0Mucosal healing in inflammatory bowel disease
-
0Interleukin 13 and its role in gut defence and inflammation
-
0Revising the classification of acute pancreatitis
Comments (0)
0/500
New Comments(0)
What do you think of this episode?